pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-384 |
Genomic Coordinates | chrX: 105344282 - 105344369 |
Synonyms | Mirn384, mmu-mir-384, Mir384 |
Description | Mus musculus miR-384 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-384-5p |
Sequence | 16| UGUAAACAAUUCCUAGGCAAUGU |38 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Tbc1d5 | ||||||||||||||||||||
Synonyms | 1600014N05Rik | ||||||||||||||||||||
Description | TBC1 domain family, member 5 | ||||||||||||||||||||
Transcript | NM_028162 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Tbc1d5 | |||||||||||||||||||||
3'UTR of Tbc1d5 (miRNA target sites are highlighted) |
>Tbc1d5|NM_028162|3'UTR 1 GCACAGGGCCCCACTGGCGGACACCCTGCTGAACCAGTGTCTTTTTCCCAGCATGCATTTGGCATTGGTTCAACCCACTG 81 GAACTCTTTACAAAAAGAGGCAACTATGCTTCTTTCAATGCACTATGTTTACCAAAATGCAGATAGAGGTTTCCAGACCC 161 TTACCTGACCCTGTGACCCTTGTTCCAATTAGGGCCAGGTCAGGTCCCCAGCTCCATACCCACTGTCAGACACAGCAGAC 241 CACATCAGAGCCACATGTCTTCCGTCCCCTCCTCCCCAGCAGCTCTGCCAGTTTACACTCAGAAGGAAAAGTTGGTTTCA 321 CAACTTCCCCTTATCAAAGCTTCAGCCACAGGGAACTTGTTGATACTGAGTGAATCTGGCAGGCAGTCTCACTCCTGCCT 401 TGGAAGCCCAACATGCCACACAGAGGGAGCAGAGCGGGTGGCTCCCAGGGCTGGAGTCAGAGTGAATTGTAGGAGCAGGG 481 TTTCAGATTAGGAATCAGATTCTTGTTTGACACAAATACAGTTCTGGACCCTGGGCTTCCTAAGCTTCAGCCACCGCTGT 561 TCCTCCTTGAACAACTGGATTTCTCCTTCCAGAGTCCCCACAGCCGGGAGTGCAGTGGCTCCACGCCAGTCTGCTCTGAG 641 ATGGTTTTAAGAGTCACAGGGCTAACATCCTTGAATTGGAGAAATGTGTCCAGAGCTCTCCGGTCAGGTCTCTGAGCATG 721 TTTAGAGCTACAGTGGCCTGTTAAATGAGGAGCACAGAGGAAAACCACATTCGCACAACCCGGAGTCAGACCTCCTGGGA 801 ATTAGACCTGGAGTTCCTTCTGTGGGAGCAGGTTTCCTGTAGAGCGTTCCAGGTACCACAAGATACAGGGCTCCTATTCA 881 ACCCCCAACACCCTATTCTTGGAGCTCAGCTGTAAACTCTGCATCCAGACACTCCAAGGATGGGCCTGCCTGCCTCGGGG 961 CCCCTGCCTGGGCTGGGTATACATGAGACATCTCCCCGTCTATTGGCCGAGTACAGAGCTGTATTGGGCACAAAGCTAGG 1041 GACAGTGGAAATGGTGGATAGATGTAGCATCTGTTAGATGTCACCTCTGCCTTCTGTCCTCCTCAGAGAGCAGCTGGGCC 1121 TCTGGGCAGTGCCCCACCCACTAATAGCATTGTAATTCTCTACAGACAGGAATGCTAATGTCAGGATGCTCTGCAGGCTT 1201 CTTAGCTGTACTGCATAGCAGGGCTGGTGGCTCACTCACATGGTGGCGGGGCTCAGTCATGGCCTCATGAATTCTACCCC 1281 CTGCCTCTGACCAGTCTTCTCAGCATTCTGAGGAGCCTGCTTGCATACATGTCCCATGAAGCTGCTCTGTAAGAATCAGG 1361 GCCACCATCCATCCCTGCTAGAAGGCTTCCAGCAAGCATTCCACTTAAAGCCTTGACATAACCGTGTCAGTACCTTAGAT 1441 CTAGTGTGGGAAGTATTGACTGATCCATCCAGGTCTGGGACAGTGCCGGCCATGTCTGTCACTGCTGAGCCCTGTCCCCA 1521 GCATCTCCTTTGCGTTGAGAATAAGGTCAATAGATAACTATCACTGGCTACCCACCAGGCCAAGAAGATGATAGGCTGAC 1601 CCATTACTGTTTGAATGGACATTTCATAACCCCTCGACCTACCTGCCCTGCCCATGCCCGTGATGTGCCCCGCTCCTGTG 1681 CTTGTGTGGGTGCCACATGAGAACCCCAGGTTCACACTGAGATGTTTCTATGGTCCCTAGGCAGGCCACTCTCTCCTTGG 1761 AAGAACCAAGGATGGAAAGCTCTTCTCTAAGTGACTCTATTCTTCGTTGGTGACCATTGCTTCCCTTGGTTACCTACACT 1841 GCTGGTTTGGGATGCATTCCGTCCCTGTTATTTTATCAGGTACTTCTGTCTAATTGTACATTTTAAAGTCCTGGATATAT 1921 AGAACCTTTTTCTTTAACCACATGGTAATCATCAGTTTTAATCTCTCACATTTTGATTATAGCAGCTAATACAGTTTTAT 2001 ACAAGCCAAGCCTAGATTAAGCCCTACTGTCGTCTGCTTTTTTATACACATTTCTGTGTTTCATGCAGTCCTCTCTGATC 2081 AGATTGGAAGTGTGAAGTAAAACATACCTGTGTGCCACAGAGGGTCGGTTCAGTGCCTCGGTTCAGTTCTCGAGAACTTC 2161 CTGGCTTAGCTTGGCAAGATGACCTTCTGCTCTGCACTAACTGCAACTTGAAGTGACCACACTGCTGCTGAGTGTAACTC 2241 TGGAGGGCAGCTGCCTCCCCGGAGCCCAGTTCTCGTAGGGGTGAATCTCCTCCGCACGGGTTGGCTGTGCTGGACAACCT 2321 TGCCAGCCATGTCTTTAGTGTCAGAAAGGCTGGACAAATGCCAAAACTCTAGTATAACCTGCTGTTCAGTACAGGTTGCT 2401 TTTGCTTGCTAAAAGCTCTCCCAGTGGCCACTAAAGACAAAGCGGGGAGCACCTGTGGCCCTGCACCGGCCAGTGCCATC 2481 TCCCTTCCCCACCCTGGAACTGCTAGGAAATGAGAGCTGGGGAAGAGGCCATGTGCATGGAGAGCTGTGGCGGCAGGCTC 2561 TTCACAGATCACATGGCCTCCTCCATGCTAGGCCCAAAAGCTGCTTCTCTCTTGTTGAAAAGAGGTGTCGTTCCTATAAC 2641 CAGGCTGGTGTGGAAGTTTTCCTTCGGTGCATGAGGCTCGGCTCATCTAGTTGATATCCCAGCAGTGCCAACAATGTCCT 2721 CACGAGCCTTGGTGCCGGAGCTCATACTGATGTAGGAAATGCCTCCTTGGCAGAGCGAGCCCACTTGATGTGTACTAATA 2801 AAGGACTACTGAGAACTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | CD4+ T cells (C57BL/6) |
Disease | MIMAT0004745 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM1013598. RNA binding protein: AGO2. Condition:CD4+ T cells
... - Loeb GB; Khan AA; Canner D; Hiatt JB; et al., 2012, Molecular cell. |
Article |
- Loeb GB; Khan AA; Canner D; Hiatt JB; et al. - Molecular cell, 2012
MicroRNAs (miRNAs) are essential components of gene regulation, but identification of miRNA targets remains a major challenge. Most target prediction and discovery relies on perfect complementarity of the miRNA seed to the 3' untranslated region (UTR). However, it is unclear to what extent miRNAs target sites without seed matches. Here, we performed a transcriptome-wide identification of the endogenous targets of a single miRNA-miR-155-in a genetically controlled manner. We found that approximately 40% of miR-155-dependent Argonaute binding occurs at sites without perfect seed matches. The majority of these noncanonical sites feature extensive complementarity to the miRNA seed with one mismatch. These noncanonical sites confer regulation of gene expression, albeit less potently than canonical sites. Thus, noncanonical miRNA binding sites are widespread, often contain seed-like motifs, and can regulate gene expression, generating a continuum of targeting and regulation.
LinkOut: [PMID: 23142080]
|
CLIP-seq Support 1 for dataset GSM1013598 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | CD4+ T cells (C57BL/6) / CD4+ T cells, WT, biological rep12 |
Location of target site | NM_028162 | 3UTR | GUUUACACUCAGAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23142080 / GSE41285 |
CLIP-seq Viewer | Link |
37 mmu-miR-384-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT577998 | Pgr | progesterone receptor | 2 | 2 | ||||||||
MIRT578191 | Narg2 | interactor of little elongation complex ELL subunit 2 | 2 | 2 | ||||||||
MIRT578276 | Mesdc2 | mesoderm development LRP chaperone | 2 | 2 | ||||||||
MIRT578464 | Ints12 | integrator complex subunit 12 | 2 | 2 | ||||||||
MIRT578486 | Il18r1 | interleukin 18 receptor 1 | 2 | 4 | ||||||||
MIRT580032 | Wdr89 | WD repeat domain 89 | 2 | 6 | ||||||||
MIRT580041 | Wdr44 | WD repeat domain 44 | 2 | 2 | ||||||||
MIRT580302 | Tomm70a | translocase of outer mitochondrial membrane 70 homolog A (yeast) | 2 | 2 | ||||||||
MIRT581000 | Six4 | sine oculis-related homeobox 4 | 2 | 2 | ||||||||
MIRT581273 | Rrad | Ras-related associated with diabetes | 2 | 2 | ||||||||
MIRT582217 | Nfatc3 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 | 2 | 2 | ||||||||
MIRT582447 | Mgea5 | meningioma expressed antigen 5 (hyaluronidase) | 2 | 2 | ||||||||
MIRT583055 | Hoxb3 | homeobox B3 | 2 | 2 | ||||||||
MIRT583626 | Strip1 | striatin interacting protein 1 | 1 | 1 | ||||||||
MIRT583683 | Amer1 | APC membrane recruitment 1 | 1 | 1 | ||||||||
MIRT583923 | Dpy19l1 | dpy-19-like 1 (C. elegans) | 2 | 2 | ||||||||
MIRT584696 | Cep170b | centrosomal protein 170B | 1 | 3 | ||||||||
MIRT585027 | Gskip | GSK3B interacting protein | 1 | 1 | ||||||||
MIRT585242 | Zfp446 | zinc finger protein 446 | 2 | 2 | ||||||||
MIRT586100 | Reep4 | receptor accessory protein 4 | 2 | 4 | ||||||||
MIRT587716 | Cd300a | CD300A molecule | 2 | 4 | ||||||||
MIRT588342 | Zfp711 | zinc finger protein 711 | 2 | 2 | ||||||||
MIRT588629 | Tnrc6b | trinucleotide repeat containing 6b | 2 | 6 | ||||||||
MIRT589300 | Pigh | phosphatidylinositol glycan anchor biosynthesis, class H | 2 | 2 | ||||||||
MIRT590164 | Eno2 | enolase 2, gamma neuronal | 2 | 2 | ||||||||
MIRT592642 | Lpar3 | lysophosphatidic acid receptor 3 | 2 | 4 | ||||||||
MIRT593646 | Tbc1d5 | TBC1 domain family, member 5 | 2 | 2 | ||||||||
MIRT595037 | Camk4 | calcium/calmodulin-dependent protein kinase IV | 2 | 2 | ||||||||
MIRT595222 | Slc16a1 | solute carrier family 16 (monocarboxylic acid transporters), member 1 | 2 | 2 | ||||||||
MIRT595455 | Ptrhd1 | peptidyl-tRNA hydrolase domain containing 1 | 1 | 1 | ||||||||
MIRT595822 | Fam227a | family with sequence similarity 227, member A | 1 | 1 | ||||||||
MIRT596023 | Cdk13 | cyclin-dependent kinase 13 | 2 | 2 | ||||||||
MIRT596361 | Serpine1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 | 2 | 2 | ||||||||
MIRT596421 | Ing1 | inhibitor of growth family, member 1 | 2 | 2 | ||||||||
MIRT596514 | Zfp9 | zinc finger protein 9 | 2 | 2 | ||||||||
MIRT599311 | Csf1 | colony stimulating factor 1 (macrophage) | 2 | 2 | ||||||||
MIRT603174 | Trp53rk | transformation related protein 53 regulating kinase B | 2 | 2 |